Patricia Carr
Chief Accounting Officer
Jazz Pharmaceuticals plc (JAZZ)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Patricia Carr
Patricia Carr is recorded as Chief Accounting Officer at Jazz Pharmaceuticals plc (JAZZ). The proxy statement of Jazz Pharmaceuticals plc reports total compensation of $1,452,210 for Patricia Carr in fiscal 2024, including a base salary of $429,954. Disclosed compensation is on record for 2 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Jazz Pharmaceuticals plc (JAZZ)
Proxy statement
Start not stated–2021-06-11
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Jazz Pharmaceuticals plc
Other people whose current roles at this company are on record from its filings.
- Bruce Cozadd CEO, Board Member
- Renee D. Gala CEO
- Renee Gala CEO, COO, Board Member
- Matthew P. Young CFO
- Philip Johnson CFO
- Renée D. Galá CFO
- Chris Tovey COO
- Renée Galá COO
- Neena M. Patil General Counsel
- Anne O’Riordan Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Jazz Pharmaceuticals plc (JAZZ) | Senior Vice President and CAO (Former Interim Principal Financial Officer) | $429,954 | $1,452,210 |
| 2023 | Jazz Pharmaceuticals plc (JAZZ) | Senior Vice President and CAO (Former Interim Principal Financial Officer) | $402,181 | $1,401,028 |
Recent activity
No call appearances or filed executive changes recorded yet.